Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial

Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial

(2020) Mohamed I. Abdelhamid et al.   International Journal of Surgery

Breast Cancer–Related Lymphedema: Risk Factors, Screening, Management, and the Impact of Locoregional Treatment

(2020) Sarah A. McLaughlin et al.   JOURNAL OF CLINICAL ONCOLOGY

Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer–Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial

(2020) George E. Naoum et al.   JOURNAL OF CLINICAL ONCOLOGY

Sentinel Node Biopsy alone or with Axillary Dissection in Breast Cancer Patients after Primary Chemotherapy

(2020) Gabriele Martelli et al.   ANNALS OF SURGERY

Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis

(2020) Wilson A. Wijaya et al.   BREAST

Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer

(2020) Massimiliano Gennaro et al.   EJSO

Near-infrared fluorescence imaging for the prevention and management of breast cancer-related lymphedema: A systematic review

(2019) Muriel Abbaci et al.   EJSO

Linfogammagrafía para la evaluación de trastornos del flujo linfático de las extremidades: informe de estándares de procedimientos técnicos de un panel de expertos de medicina nuclear italiano

(2019) Marco Maccauro et al.   Revista Espanola de Medicina Nuclear e Imagen Molecular

A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer

(2019) Martinus A. Beek et al.   EJSO

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2017) Armando E. Giuliano et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Axillary Nodal Management Following Neoadjuvant Chemotherapy

(2017) Melissa Pilewskie et al.   JAMA Oncology

The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies

(2016) Chao Han et al.   PLoS One

Systematic review of axillary reverse mapping in breast cancer

(2015) M. Ahmed et al.   BRITISH JOURNAL OF SURGERY

A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients

(2015) Tao Yue et al.   Clinical Breast Cancer

Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: A randomized clinical trial (INT09/98)

(2013) Roberto Agresti et al.   CANCER

Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema

(2013) M. Gennaro et al.   EJSO

Axillary Dissection Versus No Axillary Dissection in Older Patients With T1N0 Breast Cancer

(2012) Gabriele Martelli et al.   ANNALS OF SURGERY

Factors Associated With the Development of Breast Cancer–Related Lymphedema After Whole-Breast Irradiation

(2011) Chirag Shah et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

New anatomical classification of the axilla with implications for sentinel node biopsy

(2010) K. B. Clough et al.   BRITISH JOURNAL OF SURGERY

Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer

(2010) Masakuni Noguchi et al.   JOURNAL OF SURGICAL ONCOLOGY